APA (7th ed.) Citation

HE, M., G, P., S, C., & C, C. (2026). FcγR-driven chimeric receptor T cells in cancer therapy: A novel frontier in antibody-guided immunotherapy. Cancer cell international, 26(1), . https://doi.org/10.1186/s12935-026-04258-7

Chicago Style (17th ed.) Citation

HE, Marei, Pozzoli G, Caratelli S, and Cenciarelli C. "FcγR-driven Chimeric Receptor T Cells in Cancer Therapy: A Novel Frontier in Antibody-guided Immunotherapy." Cancer Cell International 26, no. 1 (2026). https://doi.org/10.1186/s12935-026-04258-7.

MLA (9th ed.) Citation

HE, Marei, et al. "FcγR-driven Chimeric Receptor T Cells in Cancer Therapy: A Novel Frontier in Antibody-guided Immunotherapy." Cancer Cell International, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12935-026-04258-7.